Joint Reconstruction Expected to Continue with Steady Growth
The 1H18 performance of companies that make up ~80% of the joint reconstruction market achieved 4.1% growth vs. 1H17. These...
The 1H18 performance of companies that make up ~80% of the joint reconstruction market achieved 4.1% growth vs. 1H17. These...
The 21 companies we track collectively grew +3.6% in 1H18 vs. 1H17, still on pace to reach our estimates of...
Spine accounts for 18% of the orthopaedic industry's overall revenue. In 2017, sales of spine products (excluding biologics) exceeded $9...
Sales from arthroscopy/soft tissue products in 2017 surpassed $5.3 billion and grew 6.2% vs. 2016, according to our estimates published...
Alongside their 1Q18 results, numerous players reaffirmed or updated their full-year revenue guidance. Globus Medical increased its numbers based on...
Established orthopaedic players and startups alike seek to enter the trauma segment, and we think this dynamic will make trauma...
Orthopaedic industry revenue reached $49.3 billion worldwide in 2017 and grew at 3.7%, ~$1.7 billion over 2016, according to our...
The 20 public orthopedic companies we tracked in collectively grew +3.0% in 2017 vs. 2016....
The majority of the spine market-just about 80%-is controlled by companies with annual spine revenue above $100 million. See a...
In this article, we look at such activity from the ten companies that represent #6 through #15 on our list...
Login
Register for a free account
As a guest member you get access to more articles and videos every month.